Certara (NASDAQ:CERT) Hits New 1-Year Low – Here’s What Happened

Certara, Inc. (NASDAQ:CERT) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $10.29 and last traded at $10.30, with a volume of 142876 shares changing hands. The stock had previously closed at $10.54.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Barclays cut their price target on Certara from $16.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 15th. JMP Securities reissued a “market perform” rating on shares of Certara in a research note on Wednesday, July 10th. Robert W. Baird decreased their price target on shares of Certara from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. UBS Group raised shares of Certara from a “neutral” rating to a “buy” rating and set a $16.00 price objective on the stock in a research report on Friday, September 27th. Finally, KeyCorp decreased their target price on Certara from $23.00 to $20.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. Six analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $17.08.

Certara Trading Down 4.6 %

The company has a debt-to-equity ratio of 0.28, a current ratio of 2.61 and a quick ratio of 2.61. The company has a market capitalization of $1.62 billion, a P/E ratio of -27.03, a price-to-earnings-growth ratio of 5.40 and a beta of 1.49. The firm has a fifty day moving average price of $11.55 and a 200-day moving average price of $14.26.

Certara (NASDAQ:CERT) last posted its earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). The business had revenue of $93.31 million during the quarter, compared to analysts’ expectations of $96.01 million. Certara had a positive return on equity of 3.03% and a negative net margin of 21.64%. Certara’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.10 EPS. On average, equities research analysts anticipate that Certara, Inc. will post 0.27 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Patrick F. Smith sold 5,409 shares of the business’s stock in a transaction on Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the sale, the insider now directly owns 50,091 shares in the company, valued at approximately $552,503.73. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, insider Patrick F. Smith sold 5,409 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $11.03, for a total transaction of $59,661.27. Following the completion of the transaction, the insider now owns 50,091 shares of the company’s stock, valued at approximately $552,503.73. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Leif E. Pedersen sold 51,224 shares of the company’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $11.29, for a total transaction of $578,318.96. Following the completion of the transaction, the insider now directly owns 99,704 shares in the company, valued at approximately $1,125,658.16. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.39% of the company’s stock.

Hedge Funds Weigh In On Certara

A number of hedge funds and other institutional investors have recently bought and sold shares of CERT. The Manufacturers Life Insurance Company lifted its holdings in shares of Certara by 4.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,871 shares of the company’s stock worth $317,000 after acquiring an additional 975 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in Certara by 1.6% during the first quarter. Russell Investments Group Ltd. now owns 77,753 shares of the company’s stock worth $1,375,000 after purchasing an additional 1,191 shares during the last quarter. Louisiana State Employees Retirement System boosted its holdings in shares of Certara by 2.3% in the 2nd quarter. Louisiana State Employees Retirement System now owns 54,200 shares of the company’s stock worth $751,000 after purchasing an additional 1,200 shares in the last quarter. Texas Permanent School Fund Corp increased its position in shares of Certara by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 93,729 shares of the company’s stock valued at $1,676,000 after purchasing an additional 1,213 shares during the last quarter. Finally, Blue Trust Inc. purchased a new position in shares of Certara during the 2nd quarter valued at about $26,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.